Kennedy Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-113,293
Closed -$1.12M 577
2025
Q2
$1.12M Buy
113,293
+8,018
+8% +$84.5K 0.03% 496
2025
Q1
$1.37M Sell
105,275
-412
-0.4% -$5.45K 0.03% 476
2024
Q4
$1.35M Sell
105,687
-2,998
-3% -$36.3K 0.03% 565
2024
Q3
$1.21M Sell
108,685
-1,475
-1% -$16.3K 0.03% 578
2024
Q2
$1.24M Sell
110,160
-473
-0.4% -$5.51K 0.03% 571
2024
Q1
$1.37M Sell
110,633
-1,642
-1% -$21.4K 0.03% 585
2023
Q4
$1.57M Sell
112,275
-1,768
-2% -$24.6K 0.03% 534
2023
Q3
$1.68M Hold
114,043
0.04% 490
2023
Q2
$1.47M Hold
114,043
0.03% 511
2023
Q1
$1.12M Hold
114,043
0.03% 473
2022
Q4
$1.21M Sell
114,043
-15
-0% -$174 0.03% 467
2022
Q3
$1.19M Buy
+114,058
New +$1.49M 0.04% 464
2015
Q3
Sell
-113,856
Closed -$2.67M 724
2015
Q2
$2.67M Sell
113,856
-947
-0.8% -$20.6K 0.05% 542
2015
Q1
$2.58M Sell
114,803
-146
-0.1% -$2.8K 0.05% 536
2014
Q4
$1.94M Sell
114,949
-179
-0.2% -$2.73K 0.04% 570
2014
Q3
$1.65M Sell
115,128
-1,866
-2% -$26.9K 0.03% 591
2014
Q2
$1.87M Sell
116,994
-70
-0.1% -$1.06K 0.03% 565
2014
Q1
$2.12M Sell
117,064
-3,292
-3% -$61.1K 0.04% 528
2013
Q4
$2.36M Sell
120,356
-2,506
-2% -$36.7K 0.04% 520
2013
Q3
$1.46M Sell
122,862
-1,183
-1% -$14.9K 0.03% 590
2013
Q2
$1.36M Buy
+124,045
New +$2.61M 0.03% 601

Other funds holding DVAX

Kennedy Capital Management's DVAX Position: Q3 2025 in Review

Kennedy Capital Management sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 113,293 shares — an estimated $1.12M sold.

Kennedy Capital Management first reported a position in DVAX in Q2 2013 and held it in 21 quarters. The position peaked at $2.67M in Q2 2015. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Kennedy Capital Management reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 113,293 Dynavax Technologies shares in Q3 2025, an estimated $1.12M.
  • Kennedy Capital Management first reported a position in Dynavax Technologies in Q2 2013 and held it in 21 quarters.
  • Kennedy Capital Management's Dynavax Technologies position peaked at $2.67M in Q2 2015.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.